Investing Profile

Roel Bulthuis

InvestorVC
Managing Director at INKEF Capital
inkefcapital.com/team/Amsterdam, Netherlands
Photo of Roel Bulthuis, Managing Director at INKEF Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
INKEF Capital Managing Director
$100K - $5.0M
$1.5M
12
€500M
CompanyStageDateRound SizeTotal Raised
iOnctura
Series BJun 2024$86M
$110M
Co-investors: Thijs Cohen Tervaert (INKEF Capital), Fiona MacLaughlin (Johnson & Johnson Innovation)
QurAlis
Series BMar 2023$88M
Series AMay 2020$42M
$140M
Co-investors: Amy Schulman (Polaris Partners), Laia Crespo (Sanofi Ventures), Johannes Fruehauf (Mission BioCapital), Jeffrey Moore (MP Healthcare Venture Management)
NMD Pharma
Series UnknownFeb 2022$40M
$40M
Salvia BioElectronics
Series ASep 2020$31M
$91M
Co-investors: Ivan Burkov (INKEF Capital)
VarmX
Series BJul 2020$36M
$73M
Co-investors: Hermann Hauser (Amadeus Capital Partners)
Comet Therapeutics
Series AJun 2019$29M
$29M
Co-investors: Colleen Cuffaro (Canaan Partners), Henrijette Richter (Soffinova Partners)
aveni
Series BOct 2017$10M
$10M
Bird Rock Bio
Series BMar 2014$15M
$61M
Co-investors: Richard Ulevitch (5am Ventures), Andrew Schwab (5am Ventures), Simeon J. George (SR One)